Impax Asset Management Group PLC Alnylam Pharmaceuticals, Inc. Transaction History

Impax Asset Management Group PLC

$23 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$151.41 - $196.57 $47,845 - $62,116	-316 Reduced 10.89%	2,587 $495,000
Q3 2023 Nov 07, 2023	SELL	$170.77 - $211.65 $28,177 - $34,922	-165 Reduced 5.38%	2,903 $514,000
Q2 2023 Aug 07, 2023	BUY	$185.01 - $212.05 $8,880 - $10,178	48 Added 1.59%	3,068 $582,000
Q1 2023 May 10, 2023	BUY	$182.66 - $235.53 $56,989 - $73,485	312 Added 11.52%	3,020 $604,000
Q4 2022 Feb 09, 2023	SELL	$185.53 - $241.31 $176,995 - $230,209	-954 Reduced 26.05%	2,708 $643,000
Q3 2022 Nov 08, 2022	BUY	$138.54 - $232.0 $48,489 - $81,200	350 Added 10.57%	3,662 $733,000
Q2 2022 Aug 11, 2022	SELL	$120.42 - $169.29 $94,650 - $133,061	-786 Reduced 19.18%	3,312 $483,000
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $39,044 - $53,390	307 Added 8.1%	4,098 $669,000
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $2 Million - $2.62 Million	-12,521 Reduced 76.76%	3,791 $642,000
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $11,203 - $13,710	66 Added 0.41%	16,312 $3.08 Million
Q2 2021 Aug 05, 2021	BUY	$128.63 - $176.89 $128 - $176	1 Added 0.01%	16,246 $2.75 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $13,951 - $19,325	110 Added 0.68%	16,245 $2.29 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $4.31 Million - $5.15 Million	-35,031 Reduced 68.47%	16,135 $2.1 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $2.55 Million - $3.49 Million	21,074 Added 70.03%	51,166 $7.45 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $912,254 - $1.37 Million	8,754 Added 41.03%	30,092 $4.46 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $1.76 Million - $2.53 Million	18,879 Added 767.75%	21,338 $2.32 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $183,220 - $305,481	2,459 New	2,459 $283,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.2 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.21 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.43 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.33 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.26 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account